Informations:
Erreur:
ID
13107
Description
Screening for Prostate Cancer in Older Patients (PLCO Screening Trial); ODM derived from: https://clinicaltrials.gov/show/NCT00002540
Lien
https://clinicaltrials.gov/show/NCT00002540
Mots-clés
Versions (1)
- 17/01/2016 17/01/2016 -
Téléchargé le
17 janvier 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Prostate Carcinoma NCT00002540
Eligibility Prostate Carcinoma NCT00002540
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Carcinoma NCT00002540
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
men who at the time of randomization are less than 55 or greater than or equal to 75 years of age
boolean
C0001779 (UMLS CUI [1])
malignancies, treatment for cancer, exceptions
Item
individuals undergoing treatment for cancer at this time, excluding basal-cell and squamous-cell skin cancer
boolean
C0006826 (UMLS CUI [1])
C0920425 (UMLS CUI [2])
C0007117 (UMLS CUI [3])
C0553723 (UMLS CUI [4])
C0920425 (UMLS CUI [2])
C0007117 (UMLS CUI [3])
C0553723 (UMLS CUI [4])
cancer of the colon, rectum, lung, prostate
Item
individuals with known prior cancer of the colon, rectum, lung, prostate
boolean
C0699790 (UMLS CUI [1])
C0007113 (UMLS CUI [2])
C0242379 (UMLS CUI [3])
C0600139 (UMLS CUI [4])
C0007113 (UMLS CUI [2])
C0242379 (UMLS CUI [3])
C0600139 (UMLS CUI [4])
primary or metastatic plco cancers
Item
this includes primary or metastatic plco cancers
boolean
C1514515 (UMLS CUI [1])
C0699790 (UMLS CUI [2])
C0242379 (UMLS CUI [3])
C0600139 (UMLS CUI [4])
C0029925 (UMLS CUI [5])
C0699790 (UMLS CUI [2])
C0242379 (UMLS CUI [3])
C0600139 (UMLS CUI [4])
C0029925 (UMLS CUI [5])
surgical removal of the entire colon, one lung, or the entire prostate
Item
individuals with previous surgical removal of the entire colon, one lung, or the entire prostate
boolean
C0038894 (UMLS CUI [1])
C1408858 (UMLS CUI [2,1])
C0009368 (UMLS CUI [2,2])
C1408858 (UMLS CUI [3,1])
C0024109 (UMLS CUI [3,2])
C1408858 (UMLS CUI [4,1])
C0033572 (UMLS CUI [4,2])
C1408858 (UMLS CUI [2,1])
C0009368 (UMLS CUI [2,2])
C1408858 (UMLS CUI [3,1])
C0024109 (UMLS CUI [3,2])
C1408858 (UMLS CUI [4,1])
C0033572 (UMLS CUI [4,2])
participating in another trial
Item
individuals who are participating in another cancer screening or cancer primary prevention trial
boolean
C2348568 (UMLS CUI [1])
proscar, propecia, finasteride
Item
males who have taken proscar/propecia/finasteride in the past 6 months
boolean
C0678149 (UMLS CUI [1])
C0722858 (UMLS CUI [2])
C0060389 (UMLS CUI [3])
C0722858 (UMLS CUI [2])
C0060389 (UMLS CUI [3])
finasteride additional information
Item
note: individuals who are already enrolled in the trial when their physician prescribes finasteride are not prevented from taking this medication. as a result, these participants will continue to be screened and followed just as those participants who are not on finasteride.
boolean
C0060389 (UMLS CUI [1])
tamoxifen
Item
note: men who are taking tamoxifen are not excluded from any part of the plco screening trial.
boolean
C0039286 (UMLS CUI [1])
informed consent
Item
individuals who are unwilling or unable to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
psa blood test
Item
males who have had more than one psa blood test in the past three years
boolean
C0138741 (UMLS CUI [1])
colonoscopy, sigmoidoscopy, or barium enema
Item
individuals who have had a colonoscopy, sigmoidoscopy, or barium enema in the past three years
boolean
C0009378 (UMLS CUI [1])
C0037075 (UMLS CUI [2])
C0203075 (UMLS CUI [3])
C0037075 (UMLS CUI [2])
C0203075 (UMLS CUI [3])